Dr. Noor Hisham Abdullah, director-general of the Malaysian Department of Health, said the progress was made in the use of vaccines among children aged 12-17, with the Malaysian Medicines Agency recently approved the use of a vaccine against COVID-19. Sinovac’s with that age group on Friday. However, the agency recommends the use of the vaccine. with people without underlying disease and no allergic reactions to vaccines only The public health agency is still evaluating the use of the vaccine in adolescents with underlying medical conditions. and will collect information before further approval.
It is the second vaccine approved by the Malaysian Medicines Regulatory Agency for use in young people. After approval of the vaccine from Pfizer-BioEntech since last June By starting to gradually vaccinate this age group since September 20 last. Meanwhile, the number of people under the age of 18 has reached more than 400,000 this year, up from 12,000 last year.
Data from Malaysia’s Ministry of Health as of Thursday showed that the government had already been able to vaccinate at least one dose of more than 47 percent of the 12-17-year-old population, or about 1.49 million. More than 86% of the adult population has received the full dose of the vaccine. Since the start of the vaccination program in February, in July Malaysia’s Ministry of Health previously said it would no longer use the Sinovac vaccine. If the ordered stock runs out Until the announcement of approval for the use of Sinovac again for youth groups. China also announced on Wednesday it would donate another 1 million doses of the Sinovac vaccine to Malaysia. It states that it is given on the basis of deep friendship between the two countries.
